پادکست: چه ترکیبات دارویی برای پیشگیری و درمان کمخونی در بیماران مبتلا به سرطان بیشترین اثربخشی را دارند؟ https://t.co/Hat9Kqkyvb #مرور_کاکرین مرتبط را در لینک زیر ببینید: https://t.co/0N9O65XEkf @CochraneIran #پادکست #سرطان #کمخونی https://t.co/e4Re
RT @CochraneNursing: 🩸🤔For people with #cancer, which combinations of medicines are best for preventing and treating #anaemia? 📩Check out t…
RT @CochraneNursing: 🩸🤔For people with #cancer, which combinations of medicines are best for preventing and treating #anaemia? 📩Check out t…
RT @CochraneNursing: 🩸🤔For people with #cancer, which combinations of medicines are best for preventing and treating #anaemia? 📩Check out t…
RT @CochraneNursing: 🩸🤔For people with #cancer, which combinations of medicines are best for preventing and treating #anaemia? 📩Check out t…
RT @CochraneNursing: 🩸🤔For people with #cancer, which combinations of medicines are best for preventing and treating #anaemia? 📩Check out t…
🩸🤔For people with #cancer, which combinations of medicines are best for preventing and treating #anaemia? 📩Check out the latest #CochraneReview at @CochraneLibrary. 👉🏼 https://t.co/57TypZvO7p @CochraneNursing #CochraneHongKong #cuhknursing #irondeficiency
RT @CochraneJapan: がん患者の貧血の予防と治療に最善な薬剤の組み合わせの検討 https://t.co/fpu6AZTsSv
がん患者の貧血の予防と治療に最善な薬剤の組み合わせの検討 https://t.co/fpu6AZTsSv
【がん患者における貧血治療】ESAと鉄剤の併用による貧血予防を考える場合、有効性と安全性のバランスを考慮しなければならない。ESAと鉄剤による治療は、輸血回数はおそらく減少するが、死亡率と血栓塞栓症イベントの回数は増加する可能性があることが示唆された。 https://t.co/KUmk7TLxdB
RT @CochraneIberoam: [Nueva revisión @CochraneLibrary @CochraneHaem]: El tratamiento con agentes estimulantes de la eritropoyesis ➕ hierro…
[Nueva revisión @CochraneLibrary @CochraneHaem]: El tratamiento con agentes estimulantes de la eritropoyesis ➕ hierro probablemente ⬇ el número de transfusiones de sangre en personas con cáncer, pero podría ⬆ la mortalidad y eventos tromboembólicos: https
RT @cochranenutri: Which combinations of iron supplements with medicines that stimulate bone marrow to make red blood cells (ESAs) are best…
RT @cochranenutri: Which combinations of iron supplements with medicines that stimulate bone marrow to make red blood cells (ESAs) are best…
RT @cochranenutri: Which combinations of iron supplements with medicines that stimulate bone marrow to make red blood cells (ESAs) are best…
RT @cochranenutri: Which combinations of iron supplements with medicines that stimulate bone marrow to make red blood cells (ESAs) are best…
Which combinations of iron supplements with medicines that stimulate bone marrow to make red blood cells (ESAs) are best for the prevention and treatment of anaemia in people with cancer? Read the Cochrane evidence from @CochraneHaem https://t.co/F1T3L86mA
Trending on PubMed: Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis. https://t.co/bmOdLTnIXp
RT @CochraneAus: Which combinations of medicines are best for the prevention and treatment of #anaemia in people with #cancer? Updated syst…
RT @CochraneAus: Which combinations of medicines are best for the prevention and treatment of #anaemia in people with #cancer? Updated syst…
Which combinations of medicines are best for the prevention and treatment of #anaemia in people with #cancer? Updated systematic review looks at the evidence from 96 studies. https://t.co/Z1ytYrVRgf https://t.co/unDyNy5bPo
RT @IronBiologyBot: Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer pa…
Which combinations of medicines are best for the prevention and treatment of #anaemia in people with #cancer ?@cochranecollab https://t.co/qqeOOPymQa
Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis https://t.co/wnSmhEwPwp #IronBiology #BioIron #Iron